Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax.
Saved in:
| Title: | Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax. |
|---|---|
| Authors: | Valtis YK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Nemirovsky D; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Derkach A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Sharan S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Kabel C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Ortiz R; Department of Medicine, Mount Sinai Morningside-West, New York, NY., Thompson MC; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Roeker LE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Geyer MB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. |
| Source: | Blood advances [Blood Adv] 2024 Nov 26; Vol. 8 (22), pp. 5806-5813. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
